VEGAS as a Platform for Facile Directed Evolution in Mammalian Cells
source confidence: High status: Useful updated 2026-06-19
Summary
This 2019 Cell paper introduces VEGAS (Viral Evolution of Genetically Actuated Sequences), a mammalian directed-evolution platform using Sindbis virus as a vector for heredity and diversification. The authors report 24-hour selection cycles exceeding 10⁻³ mutations per base and demonstrate evolution of transcription factors, GPCRs, and allosteric nanobodies toward functional signaling endpoints in under one week.
Useful Claims
- VEGAS uses RNA alphavirus Sindbis for heredity and diversity in mammalian cells.
- Selection is achieved through genetically actuated sequences internal to the host cell.
- Reported applications include evolving transcription factors, GPCRs, and allosteric nanobodies toward functional signaling endpoints each in less than one week's time.
- Example GPCR work evolved constitutively active mutants of MRGPRX2 in three days using decreasing concentrations of the agonist (+)-morphine.
- Authors include Justin G. English (first author) and collaborators from University of North Carolina, Duke, and other institutions.
- PubMed ID: 31280962; PMC full text also available at PMC6660416.
Reliability Notes
Peer-reviewed primary literature — high confidence for the methods and proof-of-concept results reported in the paper. Subsequent independent reviews have raised technical concerns about continuous evolution with Sindbis-based systems (packaging competition, pathogen safety, cheater emergence). Those critiques do not invalidate the original demonstrations but matter for commercial platform claims. The paper does not describe Evolution Bio as a company; linkage to any Utah spinout is inferential.